Kevin Koch, President and CEO at Edgewise Therapeutics, Inc. (EWTX), sold 3,203 shares at $8.90 ($29K) on 2023-05-02, disclosed to the SEC on 2023-05-03.
Open-market sale of $29k EWTX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EWTX | SELL | 2025-05-07 | $141K | — | Filing → |
| EWTX | SELL | 2025-03-11 | $3K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $547K | — | Filing → |